Symposium
Achievement and goals of five-year plan
JAPANESE
| Chairperson: | Issei Komuro （Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo） |
| Susumu Miyamoto （Kyoto University Graduate School of Medicine） |
The Japanese Circulation Society (JCS) and Japan Stroke Society (JSS), along with 19 others in related academic fields, announced a new project, “5-year strategy for stroke and cardiovascular diseases”, in December, 2016. Given that cardiovascular and cerebrovascular diseases are becoming serious medical and social problems in Japan having built a very longevity society, we should improve quality of management in these diseases.
The goal of the project is “5% reduction of age-matched mortality rate of cardiovascular and cerebrovascular diseases within next 5 years, and extension of healthy life expectancy”.
To achieve this goal, we adopted stroke, heart failure and vascular diseases (including acute myocardial infarction, acute aortic dissection, aortic aneurysm rapture and peripheral arterial diseases) as most serious diseases, and set up 5 strategies, “training and development”, “contemporizing healthcare”, “patient registry/database development” , “patient and public outreach” and “acceleration of clinical and basic research”.
Starting from December 2016, JCS organized the joint working group with JSS, and also coped with related medical societies to establish the working groups for each 5 strategies above.
In this symposium, we would like to discuss regarding the past 2 and a half years of outcomes and the achievements of each WG group with a view to the secondary 5-year strategies which is planned to start in 2021.
The goal of the project is “5% reduction of age-matched mortality rate of cardiovascular and cerebrovascular diseases within next 5 years, and extension of healthy life expectancy”.
To achieve this goal, we adopted stroke, heart failure and vascular diseases (including acute myocardial infarction, acute aortic dissection, aortic aneurysm rapture and peripheral arterial diseases) as most serious diseases, and set up 5 strategies, “training and development”, “contemporizing healthcare”, “patient registry/database development” , “patient and public outreach” and “acceleration of clinical and basic research”.
Starting from December 2016, JCS organized the joint working group with JSS, and also coped with related medical societies to establish the working groups for each 5 strategies above.
In this symposium, we would like to discuss regarding the past 2 and a half years of outcomes and the achievements of each WG group with a view to the secondary 5-year strategies which is planned to start in 2021.
